Thus, TTP deficiency and HuR overexpression, observed both in the invasive breast cancer patient data presented here and in the highly invasive breast cancer cell line, MDA-MB-231, is a cause–effect relationship. Here, ELAVL1 is linked to invasive breast carcinoma.